David D. Wisnoski

3.4k citations

26 papers · 1.7k indexed · h-index 17

Molecular Biology top 10%
Organic Chemistry top 2%
Cellular and Molecular Neuroscience top 5%
Oncology
Cognitive Neuroscience

Co-authors: Craig W. Lindsley William Leister Zhijian Zhao S. E. Wolkenberg Yi Wang Cyrille Sur P. Jeffrey Conn Julie A. O’Brien
Topics: Receptor Mechanisms and Signaling (7 papers)Neuroscience and Neuropharmacology Research (6 papers)Microwave-Assisted Synthesis and Applications (5 papers)
Cited by: Cellular and Molecular Neuroscience Organic Chemistry Biological Psychiatry
Journals: Biochemistry Annals of the New York Academy of Sciences Journal of Medicinal Chemistry
Partner nations: United States United Kingdom

In The Last Decade

David D. Wisnoski

26 papers receiving 1.6k citations

Peers

Countries citing papers authored by David D. Wisnoski

Since Specialization

Citations

This map shows the geographic impact of David D. Wisnoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Wisnoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Wisnoski more than expected).

Fields of papers citing papers by David D. Wisnoski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Wisnoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Wisnoski. The network helps show where David D. Wisnoski may publish in the future.

Co-authorship network of co-authors of David D. Wisnoski

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Wisnoski. A scholar is included among the top collaborators of David D. Wisnoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Wisnoski. David D. Wisnoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase 2015 ·Cell Death Discovery ·(unknown),Philip A. Harris,Rakesh Nagilla,Viera Kasparcova,Sandra C. Hoffman,Brandon Swift,Lauren Dare,Michelle C. Schaeffer,Carol A. Capriotti,Michael T. Ouellette,(unknown),David D. Wisnoski,Julie A. Cox,Michael Reilly,(unknown),John Bertin,(unknown)	115
2	Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity 2015 ·Bioorganic & Medicinal Chemistry ·Adam K. Charnley,M.A. Convery,(unknown),Emma J. Jones,(unknown),Angela Bridges,Michael T. Ouellette,Rachel D. Totoritis,Benjamin Schwartz,Bryan W. King,David D. Wisnoski,James Kang,Patrick M. Eidam,Bartholomew J. Votta,Peter J. Gough,Robert W. Marquis,John Bertin,Linda Casillas	24
3	N<sup>ω</sup>-Nitro-N<sup>ω’</sup>-Substituted Guanidines: A Simple Class of Nitric Oxide Synthase Inhibitors 2014 ·PubMed Central ·Christophe Guillon,David D. Wisnoski,(unknown),Ned D. Heindel,Diane E. Heck,Donald J. Wolff,Jeffrey D. Laskin	2
4	The Amino-Acid Substituents of Dipeptide Substrates of Cathepsin C Can Determine the Rate-Limiting Steps of Catalysis 2012 ·Biochemistry ·Jon K. Rubach,Guanglei Cui,Jessica L. Schneck,Amy Taylor,Baoguang Zhao,Angela Smallwood,Neysa Nevins,David D. Wisnoski,Sara H. Thrall,Thomas D. Meek	15
5	Phenoxyacetic acids as PPARδ partial agonists: Synthesis, optimization, and in vivo efficacy 2011 ·Bioorganic & Medicinal Chemistry Letters ·Karen A. Evans,Barry G. Shearer,David D. Wisnoski,(unknown),Steven M. Sparks,Daniel D. Sternbach,Deborah A. Winegar,Andrew N. Billin,(unknown),James M. Way,Andrea H. Epperly,Lisa M. Leesnitzer,Raymond V. Merrihew,Robert X. Xu,Millard H. Lambert,Jian Jin	8
6	Synthesis and structure–activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Karen A. Evans,David D. Wisnoski,Jian Jin,Ralph A. Rivero,(unknown),Channa Jayawickreme,(unknown),Hongshi Yu	39
7	The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK‐6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers 2010 ·Synapse ·Terence G. Hamill,Waisi Eng,(unknown),Richard Lewis,Steven Thomas,(unknown),Leslie J. Street,David D. Wisnoski,S. E. Wolkenberg,Craig W. Lindsley,Sandra Sanabria Bohórquez,Shil Patel,Kerry Riffel,Christine Ryan,Jacquelynn J. Cook,Cyrille Sur,H. Donald Burns,Richard Hargreaves	27
8	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties 2009 ·Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg,Zhijian Zhao,David D. Wisnoski,William Leister,(unknown),Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,Christopher R. Gibson,Bennett Ma,(unknown),Craig W. Lindsley,George D. Hartman	15
9	Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M1 positive allosteric modulators 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),William D. Shipe,(unknown),(unknown),David D. Wisnoski,Zhijian Zhao,James C. Barrow,William J. Ray,Lei Ma,Marion Wittmann,Matthew A. Seager,Kenneth A. Koeplinger,George D. Hartman,Craig W. Lindsley	40
10	Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),David D. Wisnoski,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,(unknown),Sookhee Ha,Hervé Schaffhauser,Cyrille Sur,D. J. PETTIBONE,Mark E. Duggan,P. Jeffrey Conn,George D. Hartman,Craig W. Lindsley	58
11	p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones 2006 ·Bioorganic & Medicinal Chemistry Letters ·S. Natarajan,David D. Wisnoski,James E. Thompson,Edward A. O’Neill,Stephen J. O’Keefe	7
12	Acetonitrile/water gas‐phase reaction products observed by use of atmospheric pressure chemical ionization: adducts formed with sulfonamides 2005 ·Rapid Communications in Mass Spectrometry ·(unknown),(unknown),(unknown),David D. Wisnoski,C. Blair Zartman,Harri G. Ramjit	6
13	A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Gene G. Kinney,Julie A. O’Brien,Wei Lemaire,Maryann Burno,(unknown),Michelle K. Clements,Tsing‐Bau Chen,David D. Wisnoski,Craig W. Lindsley,Philip R. Tiller,Sheri Smith,Marlene A. Jacobson,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	229
14	A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Julie A. O’Brien,Wei Lemaire,Marion Wittmann,Marlene A. Jacobson,Sookhee Ha,David D. Wisnoski,Craig W. Lindsley,Hervé Schaffhauser,Blake A. Rowe,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	132
15	General microwave-assisted protocols for the expedient synthesis of quinoxalines and heterocyclic pyrazines 2004 ·Tetrahedron Letters ·Zhijian Zhao,David D. Wisnoski,S. E. Wolkenberg,William Leister,Yi Wang,Craig W. Lindsley	193
16	Difference in mGluR5 Interaction between Positive Allosteric Modulators from Two Structural Classes 2003 ·Annals of the New York Academy of Sciences ·David L. Williams,Julie A. O’Brien,Wei Lemaire,Tsing‐Bau Chen,Raymond S.L. Chang,Marlene A. Jacobson,Sookhee Ha,David D. Wisnoski,Craig W. Lindsley,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn	2
17	p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold 2003 ·Bioorganic & Medicinal Chemistry Letters ·S. Natarajan,David D. Wisnoski,Suresh B. Singh,(unknown),Edward A. O’Neill,Cheryl D. Schwartz,Chris M. Thompson,Catherine E. Fitzgerald,Stephen J. O’Keefe,Sanjeev Kumar,Cornelis E. C. A. Hop,Dennis M. Zaller,Dennis M. Schmatz,James B. Doherty	32
18	Development of a Custom High-Throughput Preparative Liquid Chromatography/Mass Spectrometer Platform for the Preparative Purification and Analytical Analysis of Compound Libraries 2003 ·Journal of Combinatorial Chemistry ·William Leister,(unknown),David D. Wisnoski,Zhijian Zhao,Craig W. Lindsley	71
19	Microwave-initiated living free radical polymerization: rapid formation of custom Rasta resins 2003 ·Tetrahedron Letters ·David D. Wisnoski,William Leister,(unknown),(unknown),Craig W. Lindsley	33
20	Broadening the scope of 1,2,4-triazine synthesis by the application of microwave technology 2003 ·Tetrahedron Letters ·Zhijian Zhao,William Leister,(unknown),David D. Wisnoski,Craig W. Lindsley	56

About David D. Wisnoski

David D. Wisnoski is a scholar working on Toxicology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Microwave-Assisted Synthesis and Applications (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (565 citations), Organic Chemistry (789 citations) and Biological Psychiatry (36 citations). David D. Wisnoski has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Craig W. Lindsley, William Leister, Zhijian Zhao, S. E. Wolkenberg, Yi Wang, Cyrille Sur, P. Jeffrey Conn, Julie A. O’Brien, David L. Williams and Mark E. Duggan. Their work appears in journals such as Biochemistry, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact